ICON Public Limited Company
ICLR
Classifica tra le azioni
#1651
ICON Public Limited Company, a clinical research organization, provides... ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
Prezzo delle azioni
$168.25
Ultima sincronizzazione: 2026-10-16
Capitalizzazione di mercato
$12.98B
Variazione (1 giorno)
-3.93%
Variazione (1 anno)
-9.08%
Paese
IE
Scambia ICON Public Limited Company (ICLR)
Categoria
Healthcare
Margine operativo per ICON Public Limited Company (ICLR)
Margine operativo al October 2026 TTM: 10.15%
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di ICON Public Limited Company, il margine operativo attuale (TTM) è 10.15%. Alla fine del 2023, il margine operativo era 11.78%.
Storico del margine operativo per ICON Public Limited Company da 2001 a 2026
Margine operativo alla fine di ogni anno
| Anno | Margine Operativo | Cambia |
|---|---|---|
| 2026 (TTM) | 10.15% | -23.45% |
| 2024 | 13.26% | 12.56% |
| 2023 | 11.78% | 14.70% |
| 2022 | 10.27% | 48.63% |
| 2021 | 6.91% | -50.64% |
| 2020 | 14.00% | -9.39% |
| 2019 | 15.45% | 7.44% |
| 2018 | 14.38% | -25.26% |
| 2017 | 19.24% | 2.89% |
| 2016 | 18.70% | 4.59% |
| 2015 | 17.88% | 32.84% |
| 2014 | 13.46% | 48.40% |
| 2013 | 9.07% | 39.54% |
| 2012 | 6.50% | 56.63% |
| 2011 | 4.15% | -59.43% |
| 2010 | 10.23% | -15.52% |
| 2009 | 12.11% | 5.30% |
| 2008 | 11.50% | 4.74% |
| 2007 | 10.98% | 4.57% |
| 2006 | 10.50% | 83.57% |
| 2005 | 5.72% | -50.60% |
| 2004 | 11.58% | 4.89% |
| 2003 | 11.04% | -5.07% |
| 2002 | 11.63% | 22.04% |
| 2001 | 9.53% | 0.00% |
Margine operativo per aziende simili o concorrenti
| Azienda | Margine Operativo | Differenza del margine operativo | Il paese |
|---|---|---|---|
| 17.97% | -98.23% |
US
|
|
| 20.42% | -97.99% |
US
|
|
| -10.70% | -101.05% |
US
|
|
| 0.00% | - |
CN
|
|
| 22.23% | -97.81% |
US
|
Cos'è l'Margine operativo di un'azienda?
L'Margine operativo è un indicatore chiave per valutare la redditività di un'azienda. Margini operativi più elevati sono generalmente preferibili poiché indicano che l'azienda riesce a vendere i propri prodotti o servizi a un prezzo significativamente superiore rispetto ai costi di produzione. Si calcola dividendo gli utili per i ricavi.